News

FDA’s new approach raises questions about fall COVID vaccine availability
Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...
FDA adds new hurdle for Moderna, other Covid vaccine developers
The FDA will make it more costly to seek approval of Covid-19 vaccines, but Moderna's shareholder reacted favorable to the ...
FDA to limit covid shot approval to 65+, those with medical conditions
The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
FDA sets new COVID booster guidelines for healthy adults under 65
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk individuals
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
FDA Changes How COVID Vaccines Will Be Approved—Here’s What To Know
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
FDA sets new COVID booster guidelines requiring trials for approvals for healthy adults
The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...
US FDA advisers to consider if new COVID shots should target LP.8.1 subvariant
Advisers to the U.S. Food and Drug Administration will discuss recommendations for updated COVID-19 vaccines ahead of the ...
FDA Will Limit Approvals for Covid-19 Shots. Moderna Stock Soars.
The question weighing on Moderna and other Covid-19 vaccine stocks in recent weeks has been whether the FDA will require ...